You are here

Africa

Readability of Ebola Information on Websites of Public Health Agencies, United States, United Kingdom, Canada, Australia, and Europe

CDC IED JOURNAL  by    Enrique Castro-Sánchez , Elpiniki Spanoudakis, and Alison H. Holmes    Volume 21, Number 7- July 2015                                          

 Public involvement in efforts to control the current Ebola virus disease epidemic requires understandable information. We reviewed the readability of Ebola information from public health agencies in non–Ebola-affected areas. A substantial proportion of citizens would have difficulty understanding existing information, which would potentially hinder effective health-seeking behaviors....

Several factors, including readability of information provided (8), can help reduce health literacy deficits...It is recommended that health information materials should be written at a level typically understandable by an 11-year-old person ... anxiety or panic attributed to a highly virulent infection, such as Ebola, might hinder comprehension of related information (11).

Problem, Solution, SitRep, or ?: 

Favipiravir—a prophylactic treatment for Ebola contacts?

THE LANCET byMichel Van Herp, Hilde Declerck and Tom Decroo June 13, 2015

.. the efficacy of candidate Ebola vaccines for primary prevention has not been proven.2 Furthermore, in communities in which Ebola transmission might be ongoing, an important question is: how will such a vaccination be perceived if a vaccinated person develops Ebola? Such a scenario is possible in people who contract Ebola virus before vaccination. If a person is infected with Ebola virus before vaccination, the vaccine might have a post-exposure prophylactic effect. However, how effective this prophylaxis might be is unknown.2 Moreover, if someone is infected more than 48 h before vaccination, the post-exposure prophylactic effect is likely to be insufficient, leading to possible development of Ebola after vaccination. This scenario is likely to result in serious issues relating to community trust and acceptance of an Ebola vaccine.3 How to exclude Ebola among people presenting with post-vaccination fever is also an issue.2

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Japanese Ebola test gives results in 11 minutes: researcher

AFP     April  9, 2015

Tokyo  A Japanese research team said on Thursday it had developed a field test for Ebola that gives results in just over 11 minutes -- down from the 90-minute test used now.

The breakthrough by Nagasaki University's Institute of Tropical Medicine will allow medics to move much more quickly in treating people with the haemorrhagic fever, Professor Jiro Yasuda told AFP.

"The result time was unexpectedly short," said Yasuda of the trial conducted in Guinea last month on 100 samples, of which 47 proved positive.

The Guinean government has now asked the institute and its collaboration partner Toshiba to supply equipment to roll out the test, he added.

Read complete story.
http://news.yahoo.com/japanese-ebola-test-gives-results-11-minutes-researcher-064839139.html

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

After four months, North Korea’s Ebola quarantine comes to an end

WASHINGTON POST  BY 

TOKYO — North Korea has lifted its four-month-long Ebola quarantine, bringing an end to a period of isolation that was notable even by the Hermit Kingdom’s standards.

Embassies and international aid agencies in Pyongyang received a "note verbale" from North Korea's State Emergency Anti-Epidemic Committee informing them that the quarantine was now over for all visitors except for those arriving from a handful of west African countries. Tour operators have also been informed by their North Korean partners and the state airline that the borders are being re-opened.

With no cases of the virus east of Africa, the strictly-enforced 21 day quarantine for everyone entering North Korea — locals and foreigners alike — was puzzling and inevitably sparked theories about what the ban could really be about.

Read complete story:

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Fujifilm says tests results on Avigan as Ebola drug by end-2014

REUTERS                                                 Nov. 11, 2014
By Ayai Tomisawa and Reiji Murai

TOKYO--Fujifilm Holdings Corp said it expects its influenza drug Avigan to be approved by international government bodies to treat Ebola after it receives clinical test results as early as the end of the year.

Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. Credit: Reuters/Issei Kato

Fujifilm has been growing its pharmaceutical division through a series of mergers and acquisitions as its photography business wanes. In 2008, it bought Toyama Chemical Co, whose drug Avigan has been drafted to the global fight against Ebola.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 
Subscribe to Africa
howdy folks